Evolutionary determinants of polycystic ovary syndrome: part 1

Uğur Ünlütürk, Efe Sezgin, Bulent Okan Yildiz

Research output: Contribution to journalReview article

Abstract

Polycystic ovary syndrome (PCOS) is a common and complex genetic disorder that develops under varying degrees of hyperandrogenemic and hyperinsulinemic conditions that cause phenotypic variability ranging from mild hirsutism to anovulation and infertility. In addition to increased risk of reproductive disability, PCOS is associated with metabolic diseases including type 2 diabetes, dyslipidemia, and cardiovascular disease. Similar prevalence rates and shared genetic susceptibility of PCOS among different populations suggest that genetic risk factors were already present in the ancestors of humans. Contemporary human genetic studies inform us that the origin of human ancestors is from Africa. Sharing common susceptibility loci between Chinese and European ancestry suggests that PCOS may have persisted for more than 50,000 years, before the migration of humans out of Africa. Although PCOS is the most common cause of anovulatory infertility, its high prevalence is still a paradox. From an evolutionary perspective, the pathogenic mechanisms underlying PCOS might be candidate factors for survival advantage of the human being. Former compensatory advantageous factors may become pathogenic mechanisms underlying complex metabolic disease with prolonged life expectancy and transition to sedentary lifestyle.

Original languageEnglish (US)
Pages (from-to)33-41
Number of pages9
JournalFertility and Sterility
Volume106
Issue number1
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Metabolic Diseases
Infertility
Anovulation
Sedentary Lifestyle
Hirsutism
Inborn Genetic Diseases
Medical Genetics
Population Genetics
Genetic Predisposition to Disease
Dyslipidemias
Life Expectancy
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Survival

Keywords

  • evolution
  • genetic
  • genome-wide association study
  • Göbekli Tepe
  • human development
  • Polycystic ovary syndrome

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Evolutionary determinants of polycystic ovary syndrome : part 1. / Ünlütürk, Uğur; Sezgin, Efe; Yildiz, Bulent Okan.

In: Fertility and Sterility, Vol. 106, No. 1, 01.07.2016, p. 33-41.

Research output: Contribution to journalReview article

Ünlütürk, Uğur ; Sezgin, Efe ; Yildiz, Bulent Okan. / Evolutionary determinants of polycystic ovary syndrome : part 1. In: Fertility and Sterility. 2016 ; Vol. 106, No. 1. pp. 33-41.
@article{9aaa7a01eb764edca316cf64f2b70214,
title = "Evolutionary determinants of polycystic ovary syndrome: part 1",
abstract = "Polycystic ovary syndrome (PCOS) is a common and complex genetic disorder that develops under varying degrees of hyperandrogenemic and hyperinsulinemic conditions that cause phenotypic variability ranging from mild hirsutism to anovulation and infertility. In addition to increased risk of reproductive disability, PCOS is associated with metabolic diseases including type 2 diabetes, dyslipidemia, and cardiovascular disease. Similar prevalence rates and shared genetic susceptibility of PCOS among different populations suggest that genetic risk factors were already present in the ancestors of humans. Contemporary human genetic studies inform us that the origin of human ancestors is from Africa. Sharing common susceptibility loci between Chinese and European ancestry suggests that PCOS may have persisted for more than 50,000 years, before the migration of humans out of Africa. Although PCOS is the most common cause of anovulatory infertility, its high prevalence is still a paradox. From an evolutionary perspective, the pathogenic mechanisms underlying PCOS might be candidate factors for survival advantage of the human being. Former compensatory advantageous factors may become pathogenic mechanisms underlying complex metabolic disease with prolonged life expectancy and transition to sedentary lifestyle.",
keywords = "evolution, genetic, genome-wide association study, G{\"o}bekli Tepe, human development, Polycystic ovary syndrome",
author = "Uğur {\"U}nl{\"u}t{\"u}rk and Efe Sezgin and Yildiz, {Bulent Okan}",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.fertnstert.2016.05.010",
language = "English (US)",
volume = "106",
pages = "33--41",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Evolutionary determinants of polycystic ovary syndrome

T2 - part 1

AU - Ünlütürk, Uğur

AU - Sezgin, Efe

AU - Yildiz, Bulent Okan

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Polycystic ovary syndrome (PCOS) is a common and complex genetic disorder that develops under varying degrees of hyperandrogenemic and hyperinsulinemic conditions that cause phenotypic variability ranging from mild hirsutism to anovulation and infertility. In addition to increased risk of reproductive disability, PCOS is associated with metabolic diseases including type 2 diabetes, dyslipidemia, and cardiovascular disease. Similar prevalence rates and shared genetic susceptibility of PCOS among different populations suggest that genetic risk factors were already present in the ancestors of humans. Contemporary human genetic studies inform us that the origin of human ancestors is from Africa. Sharing common susceptibility loci between Chinese and European ancestry suggests that PCOS may have persisted for more than 50,000 years, before the migration of humans out of Africa. Although PCOS is the most common cause of anovulatory infertility, its high prevalence is still a paradox. From an evolutionary perspective, the pathogenic mechanisms underlying PCOS might be candidate factors for survival advantage of the human being. Former compensatory advantageous factors may become pathogenic mechanisms underlying complex metabolic disease with prolonged life expectancy and transition to sedentary lifestyle.

AB - Polycystic ovary syndrome (PCOS) is a common and complex genetic disorder that develops under varying degrees of hyperandrogenemic and hyperinsulinemic conditions that cause phenotypic variability ranging from mild hirsutism to anovulation and infertility. In addition to increased risk of reproductive disability, PCOS is associated with metabolic diseases including type 2 diabetes, dyslipidemia, and cardiovascular disease. Similar prevalence rates and shared genetic susceptibility of PCOS among different populations suggest that genetic risk factors were already present in the ancestors of humans. Contemporary human genetic studies inform us that the origin of human ancestors is from Africa. Sharing common susceptibility loci between Chinese and European ancestry suggests that PCOS may have persisted for more than 50,000 years, before the migration of humans out of Africa. Although PCOS is the most common cause of anovulatory infertility, its high prevalence is still a paradox. From an evolutionary perspective, the pathogenic mechanisms underlying PCOS might be candidate factors for survival advantage of the human being. Former compensatory advantageous factors may become pathogenic mechanisms underlying complex metabolic disease with prolonged life expectancy and transition to sedentary lifestyle.

KW - evolution

KW - genetic

KW - genome-wide association study

KW - Göbekli Tepe

KW - human development

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=84990028998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84990028998&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2016.05.010

DO - 10.1016/j.fertnstert.2016.05.010

M3 - Review article

C2 - 27238626

AN - SCOPUS:84990028998

VL - 106

SP - 33

EP - 41

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -